Form 4: Myomo Chief Medical Officer Sells Shares to Cover Tax Obligations from RSU Vesting
Insider Transaction Report
Myomo, Inc.'s Chief Medical Officer, Harry Kovelman, sold 5,743 shares of common stock on June 6, 2025, at $2.97 per share, solely to satisfy tax withholding requirements related to the vesting of restricted stock units.
Summary
- Harry Kovelman, Chief Medical Officer of Myomo, Inc. (MYO), reported a transaction on June 6, 2025.
- He disposed of 5,743 shares of common stock at a price of $2.97 per share.
- This sale was specifically to cover income taxes incurred from the vesting of restricted stock units (RSUs) on June 5, 2025.
- The transaction was conducted under the Issuer's 2018 Stock Option and Incentive Plan, based on an irrevocable election made by Mr. Kovelman on May 12, 2025.
- Following this transaction, Mr. Kovelman beneficially owns 90,734 shares of Myomo common stock directly.
- An associated Exhibit 24 details a Limited Power of Attorney granted by Harry Kovelman on May 15, 2025, authorizing Paul Gudonis, David Henry, and Amy Vetrano-Palmer to execute SEC filings on his behalf.
Sentiment
Score: 5
Explanation: The transaction is a routine, non-discretionary sale of shares to cover tax obligations upon RSU vesting, which is a neutral event. It does not indicate a change in management's confidence or the company's operational performance.
Positives
- The vesting of Restricted Stock Units (RSUs) indicates a compensation event for the Chief Medical Officer, aligning management incentives with shareholder value.
- The sale was for tax purposes, which is a routine and expected event for RSU vesting, rather than a discretionary sale indicating a lack of confidence.
Negatives
- The transaction resulted in a reduction of 5,743 shares from the Chief Medical Officer's direct beneficial ownership.
Risks
- The Limited Power of Attorney includes an indemnification clause stating that the undersigned (Harry Kovelman) agrees to indemnify the attorneys-in-fact and the Company from any demand, damage, loss, cost, or expense arising from any false or misleading information provided by the undersigned to the attorneys-in-fact.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This SEC Form 4 filing is a routine disclosure of an insider stock transaction, specifically a sale to cover tax obligations from RSU vesting. It does not provide information relevant to broader industry trends or competitive dynamics within the medical device or rehabilitation technology sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Harry Kovelman granted a Limited Power of Attorney to Paul Gudonis, David Henry, and Amy Vetrano-Palmer to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/G) on his behalf as an officer and/or director of Myomo, Inc. | 05/15/2025 | This is a standard corporate governance practice to facilitate timely and accurate SEC filings for insiders, ensuring compliance with reporting obligations. It does not represent a change in corporate bylaws or fundamental governance structure, but rather a procedural delegation. |
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, but for a routine tax-related purpose, which is generally not viewed negatively. The underlying RSU vesting is a positive for executive compensation alignment.
Next Steps
- The document does not mention any specific future actions, events, or milestones for the company or the reporting person, beyond the completion of this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 05/12/2025 | Date of irrevocable election made by Harry Kovelman regarding the sale of shares to cover income taxes on RSU vesting. |
| 05/15/2025 | Effective date of the Limited Power of Attorney granted by Harry Kovelman. |
| 06/05/2025 | Date of vesting of restricted stock units (RSUs) for Harry Kovelman. |
| 06/06/2025 | Date of transaction where Harry Kovelman sold shares to cover income taxes on RSU vesting. |
Keywords
Myomo, MYO, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Chief Medical Officer, Harry Kovelman, Corporate Governance, Power of Attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.